SKYWAYS AEROSPACE LIMITED

Executive Summary

SKYWAYS AEROSPACE LIMITED is currently dormant, with no trading activity or financial transactions beyond its initial share capital. While statutory compliance is good, the company shows no operational financial health indicators. Activating business operations and injecting capital would be essential next steps to improve its financial vitality and future prospects.

SKYWAYS AEROSPACE LIMITED - Analysis Report

Company Number: 14195149

Analysis Date: 2025-07-29 15:41 UTC

Financial Health Assessment for SKYWAYS AEROSPACE LIMITED

---

1. Financial Health Score: D

Explanation:
The company’s financial health score is graded as D. This reflects a dormant status with minimal financial activity and very limited financial data available. While the company is not showing distress signals, the absence of operational activity and financial transactions means there is no evidence of healthy growth or cash flow. The company is essentially in a state of financial hibernation.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Net Assets	1,000	Minimal net assets indicate the company holds only its initial share capital, no additional equity or retained earnings.
Shareholders’ Funds	1,000	Equal to net assets, confirming no profits retained or losses incurred.
Account Category	Dormant	Indicates no significant financial transactions during the year; company is inactive operationally.
Filing Status	Up to date	Accounts and confirmation statements filed on time, showing compliance with statutory requirements.
Company Age	~2 years	A relatively new company with no operational history yet.
Ownership Concentration	100% by Martin Bosman	Single controlling shareholder with full decision-making authority.

Interpretation of Vital Signs:
The company is financially inert with no operational cash flows, revenues, or expenses. It maintains only the initial £1,000 share capital on its balance sheet. This is typical for a dormant company but signals no business activity or growth. The filing compliance is healthy, indicating good governance in administrative matters.

---

3. Diagnosis

Symptoms Analysis:

• The absence of any financial transactions or operational activity (dormant status) means the company is neither generating income nor incurring costs.
• The balance sheet is static, showing only the initial capital contribution, reflecting no investment in assets or working capital.
• No liabilities or debts are present, which is positive but expected in a dormant state.
• The director and shareholder are the same individual, which simplifies control but may limit external capital or expertise.

Overall Diagnosis:
SKYWAYS AEROSPACE LIMITED is currently in a state of dormancy — akin to a patient in remission or rest. It shows no active symptoms of financial stress or growth. There is no evidence of operational health such as revenue generation, asset accumulation, or liabilities management. The company is essentially in "standby mode" with a clean but minimal financial profile.

---

4. Recommendations

To improve financial wellness and transition from dormancy to active business health, consider the following actions:

1. Activate Operations:
   Develop and implement a business plan to commence trading or manufacturing activities aligned with the company’s aerospace focus. This will create healthy cash flow and operational data.

2. Capital Injection:
   If operations require, consider additional equity investment or external funding to build working capital and fixed assets necessary for production or service delivery.

3. Financial Record Keeping:
   Once active, maintain detailed and timely accounting records to monitor cash flow, profitability, and asset utilization — the vital signs of financial health.

4. Risk Management:
   Prepare for business risks by establishing controls like budgeting, forecasting, and regular financial reviews to detect early symptoms of distress.

5. Governance and Compliance:
   Continue timely filing and compliance with Companies House obligations to avoid legal or regulatory complications.

---